Univ.-Prof. Dr. Anita Elaine Weidmann

Univ-Prof. Dr. Anita Weidmann

Professorship for Clinical Pharmacy

Work Address

Innrain 15, 6020 Innsbruck
Office hours: any time by appointment,
please register by email
Mail: anita.weidmann@uibk.ac.at
Telephone:+43 (0)512 507 58880

ORCID: https://orcid.org/0000-0003-3670-2357

Areas of Interest

Professor Weidmann's key areas of interest for PhD projects and research collaborations include:

  • The optimisation of medication therapy in patients and patient safety,
  • Medication risk associated with Delirium,
  • Evaluation based research of existing clinical services and education,
  • Needs assessment for the development of clinical services to inform legislative changes and academic curricula,
  • Implementation research for clinical pharmacy services to inform the development of necessary implementation frameworks; and
  • Academic curriculum development on a postgraduate and undergraduate level.
Teaching

  1. 740471 VU Drug Therapy & Medication Management
  2. 740530 VO Drug Therapy (AMTS)
  3. 740532 SE Drug Therapy (AMTS)
  4. 740534 UE Drug Therapy (AMTS)
  5. 740536 VO Therapy Individualization
  6. 740402 VU Drug Info
  7. 740540 VO KH Pharmacy
  8. 740927 SE Analysis of own research results
  9. 740929 SE Discussion of current research results

Requests for supervision of master theses are welcome by email to Anita.Weidmann@uibk.ac.at

Professional Experience

2021 - now         Univ. - Prof. Clinical Pharmacy, University of Innsbruck; Austria.

2025 - now         Visiting Prof. Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland. 

2021 – now        Visiting Prof. Robert Gordon University, Aberdeen, RGU

2017 – now        Visiting Prof. Karl-Franzens Universität, Graz, Austria

2020 – 2021       Academic Strategic Lead; Senior Lecturer in clinical pharmacy; Clinical Pharmacy Practice; RGU

2018 – 2020       Academic Team Lead; Senior Lecturer in clinical pharmacy; Business Development lead; RGU.

2013 - 2018        Senior Lecturer in clinical pharmacy; Pg course leader MSc Clinical Pharmacy Practice; RGU.

2008 – 2012       Lecturer in clinical pharmacy; RGU.

2008                    Pharmacy Manager, Community Pharmacy, Aberdeen, UK

2007 – 2008       Postdoctoral research fellow, Apoptosis Research Centre, Children’s Hospital of Eastern Ontario,
                             University of Ottawa, Canada.

2002 – 2007       PhD “Investigation of Hypoxia and Hyperglycaemia mediated damage in human endothelial cells”

                             Locum Pharmacist, Aberdeen Royal Infirmary, Krankenhaus, UK.

2001 – 2002       Pre-registration Pharmacist, Addenbrooke’s Hospital, Cambridge, UK

External Academic Consultancy & Professional Practice

2026                   Guest Editor - Innovative technologies and artificial intelligence. International Journal of Pharmacy Practice, Special Issue

2025                   Invited Expert, Podium Discussion. Shaping the Future of Pharmacy Services in Europe. European Parliament, Brussels

2025                   Reviewer for the National Patient Safety Award. Austrian Platform of Patient Safety (2025). 

2025                   Guest Editor - Innovative technologies and artificial intelligence. International Journal of Clinical
                            Pharmacy, Special Issue

2024 – now        Hospital Pharmacists Postgraduate Education Comission, Apothekerkammer Österreich

2024 – now        Funding application reviewer COST (European cooperation in Science & Technology)

2023 – now        Deutschsprachiges Netzwerk für Patientensicherheitsforschung

2023 – now        Uni Bonn: MSc Arzneimitteltherapiesicherheit, Lehre

2023 – now        Uni Wien: MSc Klinischer Pharmazie, Lehre

2023 – now        Scientific Board MEDCH Platform

2023 - now         Associate Editor for the International Journal of Clinical Pharmacy (Springer Nature)

2023 – now        Expert Group “Never Event List” - Österreichische Plattform Patient:innensicherheit, das
                            Bundesministerium für Soziales, Gesundheit, Pflege und Konsumentenschutz (BMSGPK)
                            und die Gesundheit Österreich GmbH (GÖG)

2022 – now        Associate Editor for the European Journal of Hospital Pharmacy (BMJ)

2022 – now        European Society of Clinical Pharmacy, Research Committee Member

2022 – now        Scientific Committee, Österreichische Plattform Patientensicherheit

2021 – 2022       Expert Group on Generic Prescribing Practices, Bundesministeriums für Soziales, Gesundheit,
                             Pflege und Konsumentenschutz, Austria

2021 – 2023       Member of the Editorial board for International Journal of Clinical Pharmacy (Springer)

2021 – now        Member of the Editorial board for Research in Social and Administrative Pharmacy (Elsevier)

2020 - 2021        North of Scotland Regional Education and Training Group member

2019 – 2020       Innovative educational co-operation with the Director for Postgraduate Education in clinical pharmacy,
                             University of Iceland, Reykjavik.

2018 – 2019       Consultancy, Medication Analysis, Professional Development Program, Austrian Chamber of
                             Pharmacists, Vienna.

2018 – 2020       External Examiner, Postgraduate MSc Clinical Pharmacy, University of Bradford.

2018 – 2020       External Examiner, Postgraduate MSc Clinical Pharmacy and CPD+ program, Keele University.

2018                    Consult, Pharmaceutical Law & Ethics Committee; Austrian Chamber of Pharmacists, Vienna.

2014 – 2017       Member of the Royal Pharmaceutical Society (RPS)  - Advanced Care Curriculum Task & Finishing group.

2013 – 2017       Member of the inaugural Royal Pharmaceutical Society (RPS) Faculty Credentialling Panel.

Academic Degrees

2019                   Leadership and Management (Level 5); Institute of Leadership and Management, London.

2008                   Doctor of Philosophy; Robert Gordon University

2005                   PgCert in Higher Education Learning and Teaching; Robert Gordon University

2004                   PgCert in Research Methods (Distinction); Robert Gordon University

2001                   MPharm (hons) (1st Class Hons); Robert Gordon University

Leadership Experience

2024 – 2028       Deputy Head; Institute of Pharmacy; University of Innsbruck; AUT

2024 – now        Deputy Head; Fakultätsrat – Faculty of Chemistry & Pharmacy; University of Innsbruck; AT

2024 – 2026       Head of the Curriculums reform commission for the UG Pharmacy degree course at Innsbruck
                             University; AUT

2023 – 2026       Head of the Professorial Commissions Pharmacology & Medicationtherapy; Faculty of Chemistry
                             & Pharmacy; Universität Innsbruck; AUT

2021 – now        Head of Clinical Pharmacy Department; University of Innsbruck; AUT

2020 – 2021       Academic Strategic Lead; Pharmacy Department; Clinical Pharmacy Practice; RGU

2018 - 2020        Academic Team Lead; Senior Lecturer in clinical pharmacy; Business Development lead; RGU.

Academic Self-Governance

2024 – now        University Ethics Lead; Faculty of Chemistry & Pharmacy; Universität Innsbruck; AUT       

2024 – now        Digitalization lead; Faculty of Chemistry & Pharmacy; Universität Innsbruck; AUT

2023 – now        Membership of the various Habilitation- & Professorial commissions for the Faculty of Chemistry &
                             Pharmacy; Universität Innsbruck; AUT   

2024 – now        Full member of the Curriculum Commission, Faculty of Chemistry & Pharmacy; Universität
                             Innsbruck; AUT

2023 – 2024       Associate member of the Curriculum Commission, Faculty of Chemistry & Pharmacy;
                            Universität Innsbruck; AUT

2022 – now        Head of the Personal mentoring System, Faculty of Chemistry & Pharmacy; Universität Innsbruck; AUT               

2014 – 2022       Member Faculty Ethics Committee, School of Pharmacy & Life Sciences; Aberdeen; UK

Third Mission

2024                    Artikel 3, §36a „Tätigkeit nach ärztlicher Anordnung“ – Änderung des Apotheken gesetzes;
                             Bundesgesetzblatt für
                             die Republik Österreich.

2024                    Medikation oder Süßigkeit, Lange Nacht der Forschung, Innsbruck

2023                    Junge Uni, Medikation oder Süßigkeit, 2x Workshop, Ausservillgraten – Uni im Dorf

Internationally Funded Research Collaborations

2024 - now         Management Committee (MC for Austria) COST (European cooperation in Science &
                             Technology) Action CA19132, European Network to Advance Best practice & technology
                             on medication adherence (ENABLE)

Professional Registrations

2017      Austrian Chamber of Pharmacists, Vienna, Austria.

2010      General Pharmaceutical Council, London, UK.

2002      Royal Pharmaceutical Society, London, UK.

2002      German Chamber of Pharmacists, Rheinland-Pfalz, Germany.

Professional Memberships

2025      Austrian Alzheimer’s Society (AAS) 

2024      European Delirium Association (EDA)

2021      Member of the Austrian Association of Hospital Pharmacists (AAHP)

2020      European Society of Clinical Pharmacy (ESCP)

2014      Senior Fellow of the Higher Education Academy (SFHEA).

2014      Member of the Royal Pharmaceutical Faculty (MFRPSII).

2012      Member of Canadian Pharmacists Association (CPhA).

Awards

2025       Teaching Award, Faculty of Chemistry and Pharmacy, 2025

2025       Springer Nature Editor of Distinction Award 2025 

2025       ERASMUS MOBILITY – University of Iceland (teaching)

2022       Best paper award 2022 – International Journal of Clinical Pharmacy award

2022       Top reviewer for International Journal of Clinical Pharmacy

Publications (since 2021)

Original studies
  1. Jónsdóttir F., Schintler JA., Stauffer R., Sigurdur G, Weidmann AE.  Exploring the association between medication, patient specific-factors and delirium in hospitalised patients: A ten-year retrospective, population-based cohort study in Iceland. BMJ Open, 2026. [Accepted for publication]
  2. Stoll J.T., Böhmdorfer-McNair, B,  Lutters, M,  Weidmann, AE. A theoretically informed interview study of strategic stakeholders on their readiness to implement a pharmacist competency framework for hospital practice. Int J Clin Pharm, 2026 [Accepted for publication]
  3. Brincat, A., Tonna, A., Vella Bonanno, P., Stewart, D., Weidmann, AE. Colorectal cancer patients’ experiences with antineoplastic agents from the perspective of their significant others: A longitudinal qualitative study. Int J Clin Pharm (2025). https://doi.org/10.1007/s11096-025-01976-2
  4. Tadic, I., Weidmann AE. Anticholinergic medicines - medication management, prescribing cascades, and deprescribing. International Journal of Clinical Pharmacy, 2025. https://doi.org/10.1007/s11096-025-01965-5.
  5. Tadic, I., Fialová, D., Hazen, A., C. Henman, M., Okuyan, B., Wirth, F., … E. Weidmann, A. (2025). Current Practices on Prescribing and Deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An Umbrella Review by the European Society of Clinical Pharmacy (ESCP). COPD: Journal of Chronic Obstructive Pulmonary Disease, 22(1). https://doi.org/10.1080/15412555.2025.2532076
  6. Spagl, K.T., Watson, E.W., Jatowt, A. et al. Evaluating a customised large language model (DELSTAR) and its ability to address medication-related questions associated with delirium: a quantitative exploratory study. Int J Clin Pharm (2025). https://doi.org/10.1007/s11096-025-01900-8
  7. Steindl-Schönhuber T, Drechsel T, Gittler G, Weidmann AE. Experiences, views and attitudes of nursing staff towards the implementation of a unit dose dispensing system for inpatients: A qualitative interview study. Exploratory Research in Clinical and Social Pharmacy.17(100566), (2025). https://doi.org/10.1016/j.rcsop.2025.100566
  8. Stoll, JT., Böhmdorfer-McNair, B., Jeske M., Weidmann AE. Development and validation of a national clinical pharmacy competency framework for hospital pharmacists in Austria: a multi-method study.  International Journal of Clinical Pharmacy. 2024.  https://doi.org/10.1007/s11096-024-01781-3
  9. Michel D, Tonna A, Dartsch D, Weidmann AE. Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders’ recommendations for mechanisms of change using the nominal group technique. International Journal of Clinical Pharmacy. 2024. 46:714-726. https://doi.org/10.1007/s11096-024-01708-y
  10. Michel D, Tonna A, Dartsch D, Weidmann AE, 2022. “Just a romantic idea” – Beliefs, experiences and perceptions of community pharmacy owners with medication reviews: a qualitative study using the FISpH. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-022-01524-2
  11. Weidmann AE, Deibl S, Hoppel M, 2022. “It is the future. Clinical pharmaceutical care simply has to be a matter of course.” - Community pharmacy clinical service providers’ and service developers’ views on complex implementation factors. Research in Social and Administrative Pharmacy. In Press: https://doi.org/10.1016/j.sapharm.2022.08.002
  12. Lindner, N., Riesenhuber, M., Müller-Uri, T., Weidmann AE, 2022. The role of the Austrian Community Pharmacist in Immunisation: A National Survey. International Journal of Pharmacy Practice. 44:409-417 https://doi.org//10.1007/s11096-021-01357-5
  13. Brincat A, Vella Bonanno P.V., Stewart D, Weidmann AE, 2021. Patients’ experiences on initiation of antineoplastic medicines for the treatment of colorectal cancer: an interpretative phenomenological study. BMJ Open. 11:e047749. http://doi.org/10.1136/bmjopen-2020-047749 
  14. Earle-Payne K, Forsyth P, Johnson CF, Harrison H, Love S, Weidman AE, 2021. General practice clinical pharmacist standards of practice for polypharmacy or chronic disease medication reviews: A consensus study. International Journal of Pharmacy Practice. 44(3):663-672. https://doi.org/10.21203/rs.3.rs-959429/v1.  – Best paper 2022 award
  15. Brincat, A., Vella Bonanno P., Stewart, D., Weidmann, AE, 2021. Patients’ misconceptions following initiation of antineopplastic treatment for colorectal cancer. European Journal of Hospital Pharmacists. http://doi.org/10.1136/ejhpharm-2021-21hpconf.131 
  16. Weidmann AE, Guðbjörnsdóttir U.K, Gunnarson P.S., Gunnarsdóttir A.I., Jónsdóttir F, 2021. Icelandic community pharmacists’ expectations of future role extensions and training requirements. Pharmacy Education. 21(1):83-91. https://doi.org/10.46542/pe.2021.211.8391 
  17. Brincat, A., Tonna, A., Vella Bonanno, P., Stewart, D., Weidmann, AE. Colorectal cancer patients’ experiences with antineoplastic agents from the perspective of their significant others: A longitudinal qualitative study. Int J Clin Pharm (2025). https://doi.org/10.1007/s11096-025-01976-2
Systematic Literature  & Scoping Reviews
  1. Tadic, I. et al. (2025) 'Current practices on Prescribing and deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An umbrella review by the European Society of Clinical Pharmacy (ESCP),' COPD Journal of Chronic Obstructive Pulmonary Disease, 22(1), p.2532076. https://doi.org/10.1080/15412555.2025.2532076.
  2. Weidmann, A.E. et al. (2025) 'Medication causes and treatment of delirium in patients with and without dementia,' Brain and Behavior, 15(7), p. e70706. https://doi.org/10.1002/brb3.70706.
  3. Weidmann, A.E. and Jónsdóttir, F. (2025) 'Deutsche Apothekerausbildung im internationalen Vergleich,' Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 68(5), pp. 477–486 https://doi.org/10.1007/s00103-025-04039-z.
  4. Weidmann A.E., Matthíasdóttir R, Proppé GB, Tadić I, Gunnarsson PS, Jónsdóttir F. Medication Causes and Treatment of Delirium in Patients With and Without Dementia. Brain Behav. 2025 Jul;15(7):e70706. https://doi.org/10.1002/brb3.70706
  5. Tadić I, Schintler J, Weidmann AE, 2024. Best possible medication history (BPMH) conducted by pharmacy students in the hospital setting: A scoping review. Am J Health Syst Pharm (2025). 2:zxaf101. https://doi.org/10.1093/ajhp/zxaf101
  6. Weidmann AE, Proppe GB, Matthiasdottir R, Tadic I, Sigurdur G, Jonsdottir F. 2024. Medication-induced delirium in patients with and without dementia: A Systematic review of published neurology guidelines International Journal of Clinical Pharmacy. https//doi.org/10.1007/s11096-024-01861-4
  7. Hochhold, D., Stewart, D., Sig Nørgaard, L., Weidmann, AE. Identification, classification, and documentation of drug relocated problems in community pharmacy practice: A scoping review. Int J Clin Pharm. 2025 Jan 8. https://doi.org/10.1007/s11096-024-01834-7
  8. Tadić I, Schintler J, Weidmann AE, 2024. Best possible medication history (BPMH) conducted by pharmacy students in the hospital setting: A scoping review. European Journal of Hospital Pharmacy. Manuscript in preparation. Accepted for publication.
  9. Stoll, JT, Böhmdorfer-McNair, B, Weidmann AE. Hospital Pharmacy Service at transition of care points: a Scoping Review. European Journal of Hospital Pharmacists. 2024 https://doi.org/10.1136/ejhpharm-2023-003836
  10. Nazar Z; Mohammad Naseralallah L; Stewart D; Paudyal V; Weidmann AE., 2024. The use of behavioural theories, models, and frameworks in pharmacy practice research: A Scoping Review. International Journal of Clinical Pharmacy. 2024;46:559-573. https://doi.org/10.1007/s11096-023-01674-x 
  11. Paudyal V; Steward D; Okuyan B; Hazen, A.; Wirth F.; Lutters M.; Cadogan C; Fialová D., Weidmann AE.; Henman M.C., 2023. Scope, content and quality of clinical pharmacy practice guidelines: a systematic review. International Journal of Clinical Pharmacy. https://link.springer.com/article/10.1007/s11096-023-01658-x 
  12. Weidmann AE, Sonnleitner-Heglmeier A, Dartsch D, 2023. Effect of patient education videos on modifying medication related health behaviours: a systematic review using the behaviour change wheel. Pharmacy Education and Counselling. https://doi.org/10.1016/j.pec.2023.107992
  13. Michel D, Tonna A, Dartsch D, Weidmann AE, 2021. Experience with the implementation of medication reviews in community pharmacies: A systematic review using the consolidated framework for implementation research. Research in Social and Administrative Pharmacy. 18(6):2944-2961. http://doi.org/10.1016/j.sapharm.2021.07.017
  14. Weidmann A.E., Matthíasdóttir R, Proppé GB, Tadić I, Gunnarsson PS, Jónsdóttir F. Medication Causes and Treatment of Delirium in Patients With and Without Dementia. Brain Behav. 2025 Jul;15(7):e70706.https://doi.org/10.1002/brb3.70706.
  15. Tadic, I., Fialová, D., Hazen, A., C. Henman, M., Okuyan, B., Wirth, F., … E. Weidmann, A. (2025). Current Practices on Prescribing and Deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An Umbrella Review by the European Society of Clinical Pharmacy (ESCP). COPD: Journal of Chronic Obstructive Pulmonary Disease, 22(1). https://doi.org/10.1080/15412555.2025.2532076 
Registered Protocols
  1. Tadic I, Philips K, Weidmann AE, 2026. The evidence and effects of pharmacist-led services on anticholinergic prescribing using medication appropriateness tools in older adults in outpatient settings: a systematic review. PROSPERO, 2026. CRD 420261327985. https://www.crd.york.ac.uk/PROSPERO/view/CRD420261327985
  2. Weidmann AE, Ágústsdóttir I, Jónsdóttir F, 2024. The gut microbiota in medication related delirium: A systematic review. PROSPERO, 2024. CRD42024601841. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=601841 
  3. Weidmann, AE., Óskarsdóttir Þ., Jónsdóttir F. Medication induced delirium in children: A Systematic Review. PROSPERO, 2024. CRD42024598459 https://www.crd.york.ac.uk/prospero/#searchadvanced
  4. Aslam, A., Tadić I., Hughes C., Jónsdóttir F., Weidmann AE. Medication associated with delirium superimposed on dementia (DSD): a systematic review. PROSPERO 2024. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=546118 
  5. Weidmann AE, Jónsdóttir F, Gunnarsson PS, 2023. Per-operative Medication induced Delirium: A systematic review. PROSPERO CRD42023443708
  6. Weidmann AE, Jónsdóttir F, Gunnarsson PS, 2023. Guidelines on how to prevent and manage peri-operative medication induced Delirium: A systematic review. PROSPERO CRD42023442726
  7. Weidmann AE, Stover Hielscher KR, Paudyal V, 2022. Current guidelines and practices on prescribing and deprescribing for patients on long-term antibiotics treatment: A systematic review. PROSPERO CRD42022381268
  8. Weidmann AE, Jónsdóttir F, Gunnarsson PS, 2022. Guidelines on how to prevent medication induced Delirium in Dementia patients: A systematic review. PROSPERO CRD42022366025
  9. Weidmann AE, Jónsdóttir F, Gunnarsson PS, 2022. Medication induced Delirium in Dementia patients: A systematic review. PROSPERO CRD42022366020
  10. Stoll, JT, Böhmdorfer-McNair, B, Weidmann AE, 2022. Competencies and strategic aims of hospital pharmacists to reduce the occurrence of avoidable patient harm – a systematic review. PROSPERO CRD42022323461
Other Publications -  scientific
  1. Tadic, I. and Weidmann, A.E. (2025) 'Anticholinergic medicines – medication management, prescribing cascades, and deprescribing,' International Journal of Clinical Pharmacy, 47(5), pp. 1532–1536. https://doi.org/10.1007/s11096-025-01965-5.
  2. Weidmann, A.E., Cadogan, C., Fialová, D. et al. Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical Pharmacy. Int J Clin Pharm (2025). https://doi.org/10.1007/s11096-025-01966-4
  3. Betul Okuyan, Martin C. Henman, Vibhu Paudyal, Anita E. Weidmann, Cathal Cadogan, Ankie Hazen, Daniela Fialová, Francesca Wirth, Monika Lutters, Bart Pouls, Zachariah Nazar, Fatma Al Raisi & Derek Stewart. Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based study. Int J Clin Pharm (2025). Epub ahed of print: https://doi.org/10.1007/s11096-025-01954-8
  4. Weidmann, AE., Jónsdóttir F. Apothekenausbildung im internationalen Vergleich. Bundesgesundheitsblatt, 2025.  https://doi.org/10.1007/s00103-025-04039-z
  5. Alves da Costa, F., Fernandez-Llimos, F., Desselle, S., Arnet, I., Babar, Z., Bond, C., Cordina, M., Garcia Cardenas, V., El Hajj, MS., Jacobsen, R., Law, AV., Nørgaards, LS., Polidori, C., Scherbakova, N., Stewart, D., Tonin, F., Weidmann, AE. The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications*. Int J Clin Pharm 47, 4–7 (2025). https://doi.org/10.1007/s11096-024-01833-8 
  6. Weidmann AE. Book Review: J Jimmy, A.R. Cox, V. Paudyal (eds): Principles and Practice of Pharmacovigilance and Drug Safety Springer International Publishing, 2024. ISBN 978-3-031-51088-5 and ISBN 978-3-031-51089-2 [eBook]. International Journal of Clinical Pharmacy, 2024. https://doi.org/10.1007/s11096-024-01862-3.
  7. Weidmann AE, Watson EW. Novel opportunities for clinical pharmacy research: Development of a machine learning model to identify medication related causes of delirium in different patient groups. International Journal of Clinical Pharmacy. 2024. 46:992-995. https://doi.org/10.1007/s11096-024-01707-z 
  8. Weidmann AE. Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities. International Journal of Clinical Pharmacy. 2024; 46:751-754. https://doi.org/10.1007/s11096-024-01705-1
  9. Wirth F; Paudyal V; Steward D; Okuyan B; Hazen, A.; Lutters M.; Cadogan C; Fialová D., Weidmann AE.; Henman M.C., 2023. Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy. 46, 548–554 (2024)  https://doi.org/10.1007/s11096-023-01695-6
  10. Weidmann AE, Cadogan CA, Stewart D, European Society of Clinical Pharmacy, 2023. How to write a successful grant application. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-023-01543-7
  11. Tadic, I., Weidmann AE. Anticholinergic medicines - medication management, prescribing cascades, and deprescribing. International Journal of Clinical Pharmacy, 2025. https://doi.org/10.1007/s11096-025-01965-5.
Other Publications – non-scientific
  1. Stoll, J., Weidmann A.E. Neuer klinisch-pharmazeutischer Kompetenzrahmen. Österreichische Apothekerzeitung (2025), 09(25): 2-4.
  2. Dartsch D, Weidmann AE. 2024. Vermittlung von AMTS-Kompetenzen: Wissen, Tun und Können. Pharmakon. 2024, Ausgabe 5/24. https://www.dphg.de/artikel/pharmakon-5-2024---arzneimitteltherapiesicherheit 
  3. Hoti, K., Weidmann AE. Encouraging dissemination of research on the use of artificial intelligence and related innovative technologies in clinical pharmacy practice and education: call for papers. International Journal of Clinical Pharmacy. 2024. 46:777-779. https://link.springer.com/article/10.1007/s11096-024-01777-z
  4. Michel, DE, Tonna, AP, Weidmann, AE, Dartsch, DC, 2021. Medikationsanalyse einführen, aber wie? Stellschrauben für eine erfolgreiche Implementierung. Deutsche Apothekerzeitung, 21, pp.1934-1937 https://www.deutsche-apotheker-zeitung.de/daz-az/2021/daz-21-2021/medikationsanalyse-einfuehren-aber-wie 
  5. Michel, DE, Weidmann, AE, Dartsch DC, 2023, Medikationsanalyse: Nur eine romantische Idee? Was Apothekeninhaber über die neue pharmazeutische Dienstleistung denken. Deutsche Apothekerzeitung, 7, pp.2400-2401
Keynote presentations

2025                      Jónsdóttir F, Weidmann AE. Prescribing rights for clinical practice – where to start? European Society of Clinical
                               Pharmacy, Egmond aan Zee, 2025.
                               https://escpweb.org/wp-content/uploads/2025/03/ESCP-Spring-Workshop-Egmond-aan-Zee-2025-Program.pdf

2025                      Keynote speaker, Pharmaceutical Care Network Europe (PCNE); Application of behavioural theories, models,
                               and frameworks in pharmacy practice research. Innsbruck (Austria)

2024                      Keynote speaker, European Society of Clinical Pharmacy, Dementia/Delirium care: Implementing and scaling
                               sustainable clinical pharmacy practice. Krakow (Poland)

2021                      Keynote speaker, Gesundheit Österreich GmbH, Pharma-Plattform, Arzneimitteltherapiesicherheit –
                               Alte Herausforderungen, neue Wege. Online (Austria)

Dissertations

2026 – present      PhD student (principal supervisor) “Medication risks associated with delirium in the per-operative patient cohort”

2026 – present      PhD student (principal supervisor) “Medication risks associated with delirium in oncology patients”

2024 – present      PhD student (principal supervisor) “Medication risks associated with delirium superimposed on dementia”

2022 – present      PhD student (principal supervisor) “Nature and frequency of medication related problems in everyday
                                 community pharmacy practice: A national study in Austria”

2021 – 2025           PhD student (principal supervisor) „Development of a competency framework for Austrian hospital pharmacists “
                                 – COMPLETED

2018 - 2024            PhD student (principal supervisor) “Implementation of medication reviews in German community pharmacies”.
                                 – COMPLETED [https://doi.org/10.48526/rgu-wt-2795705]

2015 - 2023            PhD student (principal supervisor) “An exploration of the patients’ lived experience with cancer medicine in Malta”.
                                 – COMPLETED [https://doi.org/10.48526/rgu-wt-2270694]

2011 - 2015            Doctorate in professional practice (DPharm) (second supervisor) “Hospital Electronic Prescribing and medicines
                                 administration system implementation into a district general hospital: A mixed method evaluation of discharge
                                 communication”.
                                 – COMPLETED [http://hdl.handle.net/10059/1581]

 

Nach oben scrollen